Posted in | News | Manganese | Mining Business

Elcora Prepares a Comprehensive Mining Plan for Ermazon Manganese Concession in Morocco

ELCORA ADVANCED MATERIALS CORP., (the "Company" or "Elcora"), is pleased to announce that following the very positive Manganese Ore lab test results previously announced, it is preparing a comprehensive mining plan for its Ermazon Manganese concession (16 km²) named “Atlas Fox Deposit” in Morocco.

The plan will be based on detailed maps of the former French Mine located on its concession allowing for faster and more efficient production. Heavy machinery and production equipment are already being shipped on-site. The Atlas Fox Deposit had been mined until the mid-fifties when the French rule in Morocco came to an end leaving on-site about 40 extracted Manganese ore piles and numerous surface veins and pits.

At the same time and in order to maximise respective shareholders value, Elcora and Gold Lion have mutually agreed to rescind the Option Agreement to purchase up to 50% interest in the Manganese concession therefore allowing Elcora to retain 100% ownership of its valued Manganese concession while permitting Gold Lion to focus on opportunities more inline with its current business model.

As a result, Elcora will return the 5,000,000 common shares of Gold Lion, issued at deemed price of $0.05 per share, and the cash payment of $75,000 for the initial 25% interest in the license. Neither party will be required to pay the other a termination fee as a result of the rescind of the option agreement.

Troy Grant, Elcora’s CEO commented, “Given the latest Manganese Ore test results, it was important for us to retain 100% of the Atlas Lion Deposit and build additional shareholders’ value. Our focus is now to start producing ore as soon as possible and the Mining Plan along with bringing the necessary equipment are important steps towards it. Our local Moroccan team is diligently working on getting the last Government requirements with the objective to start production before the end of 2022.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.